Indefinite Delivery Contract 75D30120D07983

Award Date 5/7/20
Last Date to Order 4/22/21
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Quest Diagnostics Incorporated for surge serology testing services. The contract established a potential value of $23.75 million for Quest Diagnostics to provide COVID-19 antibody testing from its Secaucus, New Jersey laboratory in support of the CDC's pandemic response. A $14 million firm fixed price delivery order to Quest Diagnostics expanded the scope of work. Under the delivery order,...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Bioreference Health LLC for surge serology testing in support of COVID-19 response efforts. The potential value of the contract vehicle is $23.75 million. Under the contract, Bioreference Health will perform testing services out of its laboratory in Elmwood Park, New Jersey. A $1.85 million firm fixed price delivery order was issued to Bioreference Health to conduct testing from July 30,...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Corgenix Medical Corporation, a foreign-owned, small disadvantaged business manufacturer of goods. The $23,650,000 contract is for "SURGE SEROLOGY TESTING" services, with a period of performance from April 23, 2020 to April 22, 2021. As an IDC, this contract allows the CDC to issue task orders for serology testing services as needed. The contract does not appear to have any...
The Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a $118 million ceiling value to Aegis Sciences Corporation, a for-profit forensic toxicology and healthcare laboratory, to provide "TEST SURGE AND DATA SHARING" support services. Under this IDIQ, the CDC has issued two firm fixed price and time and materials task orders to Aegis. The first is a $2,427,648.50 firm fixed price task order with a period of...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide serology surge testing services. The contract has a ceiling value of $23,750,000 and a period of performance from April 2020 to April 2021. As a multiple award IDC, this vehicle provides the CDC with flexible access to Battelle's scientific and technical capabilities in areas...
The Centers for Disease Control and Prevention (CDC) awarded a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) contract titled "Test Surge and Data Sharing" to Quest Diagnostics Incorporated, a provider of diagnostic information services. The $118 million IDIQ contract has a period of performance through September 2029 and allows the CDC to procure clinical laboratory testing and analysis services from Quest Diagnostics on an as-needed basis. The contract does not have...
This single award indefinite delivery contract from the Department of Health and Human Services' Food and Drug Administration to Laboratory Corporation of America holds a potential value of $4.6 million to provide COVID-19 testing services for FDA employees and contractors. Two firm fixed price delivery orders have been awarded against the contract to date, for $149,949.15 and $20,069.53 respectively, with periods of performance through July 2023 and March 2022. Place of performance will be...
The federal contract IDV award is a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (LabCorp), a leading global life sciences company. The contract, titled "Test Surge and Data Sharing," has a ceiling value of $118,000,000 and a period of performance through September 5, 2029. LabCorp, doing business as Labcorp, is the prime contractor and provides comprehensive...
The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, awarded a $5 million indefinite delivery contract to Signify Health LLC, doing business as Censeohealth, to provide COVID-19 testing services for nursing home residents and staff in Dallas, Texas. Under this contract, Signify Health has received multiple firm fixed-price delivery orders totaling over $2.5 million since May 2020 to supply COVID-19 tests. This contract supports the CDC's...
The federal contract IDV award W9127Q09A0004 is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $100,000.00, issued by a U.S. government agency to awardee Laboratory Corporation Of America. The contract's ultimate completion date is September 30, 2011 and it is for the provision of lab services. As the prime contractor, Laboratory Corporation Of America Holdings, the parent company of the awardee, has a demonstrated capability to provide specialized laboratory testing...
  • 75D30120D07983
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The Centers for Disease Control and Prevention awarded an indefinite delivery contract to Laboratory Corporation of America Holdings to provide surge serology testing services in support of COVID-19 response efforts. The multiple award contract has a potential value of $23.75 million and was awarded on May 7, 2020 to aid the agency through April 22, 2021.

Two firm fixed price delivery orders have been issued against the contract to date. Laboratory Corporation will perform testing from its location in Burlington, North Carolina. The first order, awarded January 14, 2021, is valued at $533,990 and tasks the contractor to provide serology testing through April 26, 2021. The second order, awarded August 5, 2020, has a value of $1,249,400 and requires testing through December 16, 2020. No subcontractors or socioeconomic set asides were specified under any of the awards.

The delivery orders aim to expand the CDC's coronavirus diagnostic testing capacity during the pandemic by procuring surge serology testing services from Laboratory Corporation. As the lead federal agency for disease control and prevention, the CDC coordinates public health efforts, conducts research, and provides guidance, funding, and technical assistance to state and local governments regarding health issues like infectious diseases.

Generated 1/4/24, 10:41 PM